KEGG   DISEASE: 尿細管性アシドーシス IV 型
エントリ  
H00243                                                             
名称    
尿細管性アシドーシス IV 型
  下位グループ
偽性低アルドステロン症 I 型 (PHA1)
偽性低アルドステロン症 II 型 (PHA2)
Gordon 症候群
  上位グループ
高血圧症 [DS:H01633]
尿細管性アシドーシス [DS:H02310]
概要    
Renal tubular acidosis (RTA) is characterized by metabolic acidosis, a severe disturbance of extracellular pH homeostasis, due to renal impaired acid excretion. Type 4 RTA is a heterogeneous group of disorders associated with hyperkalemia due to aldosterone deficiency or impairment in aldosterone molecular signaling. Primary pseudohypoaldosteronism type 1 (PHA1) is characterized by salt-wasting, hyperkalemia, and metabolic acidosis in the presence of markedly elevated plasma renin activity and aldosterone concentration. In the autosomal dominant form, aldosterone resistance is due to heterozygous mutations in the mineralocorticoid receptor gene. In the autosomal recessive form, aldosterone resistance is caused by loss-of-function homozygous mutations in the genes encoding one of the three constitutive subunits (alpha, beta, and gamma) of the epithelial Na+ channel (SCNN1A, SCNN1B, and SCNN1G). Other inherited cause of type 4 RTA includes hyperkalaemia associated with hypertension and low or normal levels of plasma aldosterone. This syndrome is called pseudohypoaldosteronism type 2 (PHA2), or Gordon's syndrome, which results in a renal aldosterone resistance. Mutations in the genes encoding WNK1 and WNK4 kinases (WNK1 and WNK4), which regulate ion-transporters on renal tubules, were identified in patients with PHA2. Acquired hyperkalemic RTA is observed in the context of mineralocorticoid deficiency, systemic lupus erythematosus, and AIDS nephropathy. It is also often seen in a number of tubulointerstitial renal diseases. Finally, a great number of drugs may induce hyperkalemic RTA.
カテゴリ  
泌尿器系疾患
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 16 泌尿生殖器系の疾患
  尿路系の疾患
   GB90  明示された腎または尿管の疾患
    H00243  尿細管性アシドーシス IV 型
パスウェイに基づく疾患分類 [BR:jp08402]
 内分泌系
  nt06325  ホルモンとサイトカインのシグナリング
   H00243  尿細管性アシドーシス IV 型
パスウェイ 
hsa04960  Aldosterone-regulated sodium reabsorption
hsa04928  Parathyroid hormone synthesis, secretion and action
ネットワーク
nt06325 Hormone/cytokine signaling
病因遺伝子 
(PHA1A) NR3C2 [HSA:4306] [KO:K08555]
(PHA1B1) SCNN1A [HSA:6337] [KO:K04824]
(PHA1B2) SCNN1B [HSA:6338] [KO:K04825]
(PHA1B3) SCNN1G [HSA:6340] [KO:K04827]
(PHA2B) WNK4 [HSA:65266] [KO:K08867]
(PHA2C) WNK1 [HSA:65125] [KO:K08867]
(PHA2D) KLHL3 [HSA:26249] [KO:K10443]
(PHA2E) CUL3 [HSA:8452] [KO:K03869]
リンク   
ICD-11: GB90.44
ICD-10: N25.8
MeSH: D011546
OMIM: 177735 264350 620125 620126 145260 614491 614492 614495 614496
文献    
  著者
Pereira PC, Miranda DM, Oliveira EA, Silva AC
  タイトル
Molecular pathophysiology of renal tubular acidosis.
  雑誌
Curr Genomics 10:51-9 (2009)
DOI:10.2174/138920209787581262
文献    
  著者
Rodriguez-Soriano J
  タイトル
New insights into the pathogenesis of renal tubular acidosis--from functional to molecular studies.
  雑誌
Pediatr Nephrol 14:1121-36 (2000)
DOI:10.1007/s004670000407
文献    
  著者
Rodriguez Soriano J
  タイトル
Renal tubular acidosis: the clinical entity.
  雑誌
J Am Soc Nephrol 13:2160-70 (2002)
DOI:10.1097/01.ASN.0000023430.92674.E5
文献    
PMID:9662404 (PHA1A)
  著者
Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP
  タイトル
Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
  雑誌
Nat Genet 19:279-81 (1998)
DOI:10.1038/966
文献    
PMID:8589714 (PHA1B1 PHA1B2)
  著者
Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP
  タイトル
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.
  雑誌
Nat Genet 12:248-53 (1996)
DOI:10.1038/ng0396-248
文献    
PMID:8640238 (PHA1B3)
  著者
Strautnieks SS, Thompson RJ, Gardiner RM, Chung E
  タイトル
A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families.
  雑誌
Nat Genet 13:248-50 (1996)
DOI:10.1038/ng0696-248
文献    
PMID:11498583 (PHA2B PHA2C)
  著者
Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP
  タイトル
Human hypertension caused by mutations in WNK kinases.
  雑誌
Science 293:1107-12 (2001)
DOI:10.1126/science.1062844
文献    
PMID:22266938 (PHA2D PHA2E)
  著者
Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Valimaki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP
  タイトル
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
  雑誌
Nature 482:98-102 (2012)
DOI:10.1038/nature10814
LinkDB    

» English version

DBGET integrated database retrieval system